Express Scripts Holding Company (NASDAQ:ESRX) – GSK gets a lift as Express Scripts reinstates lung drug Advair

[Reuters - UK Focus] – * Advair restored to Express Scripts 2015 formulary list * GSK diabetes drug Tanzeum not included in Express (NYSE: EXPR – news) list LONDON, Aug 4 (Reuters) – . . . → Read More: Express Scripts Holding Company (NASDAQ:ESRX) – GSK gets a lift as Express Scripts reinstates lung drug Advair Similar Articles: Company Update (NASDAQ:ESRX): Express Scripts Announces 1st Quarter Results Stock Update: Pfizer Inc (NYSE:PFE) – Pfizer lung cancer drug fails in two large studies Merck (XETRA:MRK.DE) – Germany’s Merck looks for deals to lift U.S. drug sales